• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
In Clinical Practice: Cardiovascular Risk Management

In Clinical Practice: Cardiovascular Risk Management

9780443101748
120,91 zł
108,82 zł Zniżka 12,09 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 108,82 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
For many years, individual cardiovascular risk factors have been dealt with in isolation, often by specialists with an interest in one particular risk factor, for example hypertension or hypercholesterolaemia. There has recently been a move to emphasise the importance of reducing global cardiovascular risk, which requires clinicians to address any one of a number of different risk factors. The interplay between these various factors is important in our understanding of development of cardiovascular disease and, similarly, the synergistic effects of targeting different risk factors is important in risk reduction. This text provides a comprehensive and up-to-date review of modern cardiovascular risk management. It belongs to the In Clinical Practice series, which incorporate multiple illustrations using novel and effective formats. Data are frequently presented as bullet point lists or tables so that the key information is clearly available. The emphasis is on overall cardiovascular risk reduction throughout, with integration of lifestyle and pharmacological interventions.
Szczegóły produktu
33283
9780443101748
9780443101748

Opis

Rok wydania
2006
Numer wydania
1
Oprawa
miękka foliowana
Liczba stron
160
Wymiary (mm)
210 x 280
Waga (g)
308
  • INTRODUCTION
    CARDIOVASCULAR DISEASE PREVENTION
    LIFESTYLE
    SMOKING CESSATION
    OBESITY
    DIABETES MELLITUS
    DYSLIPIDAEMIA
    HYPERTENSION
    ANTIPLATELET THERAPY
    PATIENT ISSUES AND COMPLIANCE
    CONCLUSION
Komentarze (0)